A preterm female infant presented with intractable hypoglycaemia within 10 minutes of delivery. Normoglycaemia could be maintained only by the intravenous infusion of glucose at a rate of 20-22 mg/kg/min. Persistent hyperinsulinaemic hypoglycaemia ofinfancy was diagnosed from an inappropriately raised plasma insulin concentration (33 mU/l) at the time of hypoglycaemia (blood glucose <0 5 mmolIl). Medical treatment with glucagon, somatostatin, and diazoxide led to only a modest reduction in the intravenous glucose requirement; a 95°/0 pancreatectomy was performed and histological 'nesidioblastosis' confirmed. In vitro electrophysiological studies using patch clamp techniques on isolated pancreatic 1 cells characterised the ionic basis for insulin secretion in nesidioblastosis. The 1 cells were depolarised in low ambient glucose concentrations with persistently firing action potentials; these were blocked reversibly by the calcium channel blocking agent verapamil. Persistent postoperative hyperinsulinaemic hypoglycaemia was treated with oral nifedipine. This increased median blood glucose concentrations from 3-5 to 4-8 mmoVI and increased in duration the child's tolerance to fasting from 3 to 10.5 hours. These data allude to an abnormality in the ionic control ofinsulin release in nesidioblastosis and offer a new logical approach to treatment which requires further evaluation.
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Hypoglycaemia is the most common metabolic abnormality in childhood and, when K+ATP channel inhibition following glucose metabolism leads to depolarisation of the 13 cell. This leads to activation of voltage dependent L-type calcium channels and the net influx of calcium through these channels leads to an increase in cytosolic calcium concentration.14 15 A rise in intracellular calcium is a prerequisite for exocytosis and the secretion of insulin.
Recent advances in the molecular genetics of PHHI have provided new insight into the pathophysiology of this disease.1619 These developments have highlighted the fundamental importance of the ionic control of insulin secretion.
We report for the first time a study of electrical events in isolated intact 13 cells from a premature infant with PHHI. These in vitro studies were followed by a successful clinical trial of the use of the calcium channel blocking agent nifedipine.
Methods

ISLET ISOLATION
Islets were isolated from a portion of the resected pancreas using a modification of established procedures for the isolation of adult human islets from heart-beating cadaver organs.20 In brief, a portion of the excised pancreas was cut into small pieces and incubated at 38°C in Hanks solution containing 3 mg/ml Clostidium histolyticum collagenase (Boehringer Mannheim type P). Digestion of the pancreas was assessed by the appearance of freely liberated diphenylthiocarbazone stained islets; digestion was stopped by using an excess of fetal calf serum. Isolated cleaved islets were purified using a small scale FicollTM density gradient. Despite these procedures the yield of isolated islets was low (the 2 g of pancreatic tissue available to us produced only 200-300 islets). Once isolated, the islets were maintained for a short period of time (2) (3) (4) (5) (6) (7) (Bayer) . When the capillary sample fell to 2-6 mmol/l or lower a whole blood glucose was measured in the laboratory within 5 minutes. The fast was terminated if blood glucose in the laboratory was below 2-6 mmol/l, and the infant fed. On termination of the fast additional blood was drawn for simultaneous measurement of glucose, insulin, and other metabolic intermediates.
STATISTICS
Median blood glucose concentrations were compared using a Kruskal-Wallis one way analysis of variance (ANOVA) on ranks, and individual comparisons made using a Mann Whitney rank sum test. Parametric data were compared using Student's unpaired t test.
Case report
The patient is the first child of non-consanguineous Caucasian parents and was born at 31+5 weeks gestation following an emergency lower segment caesarean section because of moderately severe pre-eclampsia. No cardiorespiratory resuscitation was required, but a blood glucose concentration of <0 5 mmol/ was documented at 10 minutes of age. The child was given an intravenous bolus of glucose, but recurrent hypoglycaemia could only be prevented by the administration of a continuous intravenous infusion of glucose at a rate equivalent to not less than 20-22 mg glucose/kg/min. With the start of a concurrent intravenous infusion of glucagon ( Ongoing difficulties with unpredictable episodes of hypoglycaemia despite this maximal medical therapy led to a 95% pancreatectomy, performed at the age of 50 days. The histopathological appearance of the pancreas was consistent with that of 'nesidioblastosis', with hyperplasia of the , cells and ducto-insular endocrine cell proliferation.23
Blood glucose concentrations appeared to be stable postoperatively on a three hourly feeding regimen without any medical adjuncts, and with an assessed glucose intake of 8 mg/kg/min. She was therefore transferred back to her local hospital to monitor the natural history of the condition. During the next eight weeks she developed recurrent episodes of hypoglycaemia associated with an increase in her glucose requirement to 13 mg/kg/min and a reduced tolerance to fasting.
She was readmitted to Great Ormond Street Hospital at the age of 5 months for a further assessment. A tolerance of three hours of fasting before the onset of hypoglycaemia was confirmed. Our in vitro studies (see below) performed on islets isolated from the infants pancreatectomy specimen had shown that ,B cell calcium dependent action potentials could be blocked with verapamil. We therefore undertook a therapeutic trial of the calcium channel blocking agent nifedipine rather than proceeding directly to a total pancreatectomy.
After obtaining parental consent and after a 48 hour period in which blood sugars were measured preprandially, the short acting form of nifedipine was started at a dosage of 0-25 mg/kg/d, given at eight hourly intervals. No discernible side effects on blood pressure or on cardiac conduction were noted; no increase in blood glucose concentrations was seen (fig 1,  table) . On increasing the dose to 0 5 mgfkg/d there was a highly significant increase in blood glucose concentrations (median 3-5 mmol/l pre-nifedipine, 4-8 mmol/l on nifedipine) (table). Fasting tolerance increased from 3-3 hours to 4-5 hours on this regimen. Problems were encountered with precipitous hypoglycaemia as the medication wore off and these problems were not overcome by giving the nifedipine in four divided doses. An increase in nifedipine dose to 0-7 mg/kg/d and conversion to a slow release formulation dramatically increased her fast tolerance to over 10-5 hours (fig 2) , with an increase in the median pre- Fast duration (hours) Figure 2 Blood glucose concentrations before and duringfasting before and after the sta of nifedipine treatment. Fasts were started at time= 0 on the graph. The dotted line represents a glucose concentration of 2-6 mmol/l which was the concentration below whici fasts were terminated. 0 pre-nifedipine; * nifedipine 0.5 mg/kg/d in three divided doses; A nifedipine SR (slow release) 0 
problems to manage in paediatric medicine. A variety of descriptive clinical terms has been applied to the condition; that most frequently used is 'pancreatic nesidioblastosis'. Milner27 has provided a comprehensive review of the history of the condition and the controversies which surround the debate on its pathophysiology.
Although the diagnosis of PHHI is straightforward (by demonstrating, in a single blood sample drawn at the time of hypoglycaemia, the characteristic inappropriate increase in plasma insulin for the degree of glycaemia together with low concentrations of fatty acids and ketone bodies),1 in many children the currently available medical treatments may be ineffective, and subtotal or total pancreatectomy may be the only means of controlling the hypoglycaemia. Throughout the period of investigation and initial management, there is the ever present risk of unpredictable and severe episodes of hypoglycaemia, with resultant neurological damage.
Effective medical treatment thus demands a comprehensive understanding of the cellular pathophysiology of PHHI, which has been lacking until recently.
In normal pancreatic 13 cells the electrophysiological events which regulate insulin secretion are coordinated by ATP sensitive potassium (K+ATP) channels in the 1 cell membrane.1" Open K+ATP channel events in resting 13 cells help to maintain the negative intracellular resting membrane potential generated by Na/K-ATPase by allowing potassium efflux. Changes in intracellular ATP concentration after exposure to glucose leads to the closure of the potassium channels, causing membrane depolarisation and the opening of voltage gated calcium channels. This influx of calcium manifests as action potentials which increase the intracellular calcium concentration, thereby providing the signal for initiation of exocytosis and insulin secretion.'4 Current established pharmacological treatments are able to influence this secretory process where it is not disturbed by the disease process itself. In normal 1 cells both diazoxide and somatostatin cause potassium channel activation, leading to a hyperpolarisation of the membrane potential and termination of the action potentials." 12 Glucagon produces its hyperglycaemic effect by inducing glycogenolysis within the liver. In the isolated 13 cell, however, glucagon increases intracellular cyclic AMP and may increase insulin secretion. The effects of combinations of these three agents are probably more complex. Pharnacological blockade of 1 cell calcium channels which we describe here targets another key process in insulin secretion and provides a welcome addition to our currently limited therapeutic armamentarium in nesidioblastosis. then it is reasonable to speculate that a mutation in the gene encoding the protein could lead to altered K+ATP channel activity and persistent 13 cell depolarisation which will eventually result in insulin secretion.
Many questions still remain to be answered. The use of modem molecular biological and electrophysiological technologies has allowed considerable progress in our understanding of the pathophysiology of PHHI, and collaborative studies are under way in our laboratories to match clinical phenotype with electrophysiological phenotype and genotype. The possibility of linkage of the PHHI locus in this patient to that of Axenfeld's anomaly poses a further tantalising question.
We suggest that it is now extremely important to mount prospective collaborative studies on all resected pancreases to explore these concepts further and to undertake linkage analysis on affected families to ensure that non-SUR mutations are not missed. Knowledge of the molecular physiology of the 1 cells in individual cases and the mechanisms and magnitude of their responses to pharmacological agents in vitro will allow specific treatments to be 'designed' for those children who prove refractive to diazoxide, somatostatin, or partial pancreatectomy, and will also aid clinical decision making with regard to the need or otherwise for a further pancreatic resection.
Questions may surround the long term use of calcium channel blocking agents because of effects on other organs whose function depends critically on the state of membrane depolarisation and calcium influx. A decision was taken in this patient to use nifedipine rather than verapamil because it has less effect on myocardial function, and no specific side effects were noted in this case. More work is needed to define the place of calcium channel blockade in the routine management of PHHI.
CONCLUSIONS
Electrophysiological studies in isolated I1 cells from a preterm infant with severe hyperinsulinism have focused on the fundamental importance of ionic events as the final common pathway for the initiation of insulin secretion. See annotation on p 369.
